{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:41:19Z","timestamp":1793418079755,"version":"4.5.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>To provide an update of vascular malformation syndromes by reviewing the most recent articles on the topic and following the new International Society for the Study of Vascular Anomalies (ISSVA) 2018 classification.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>This review discusses the main features and diagnostic approaches of the vascular malformation syndromes, the new genetic findings and the new therapeutic strategies developed in recent months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Some vascular malformations can be associated with other anomalies, such as tissue overgrowth. PIK3CA-related overgrowth spectrum (PROS) is a group of rare genetic disorders with asymmetric overgrowth caused by somatic mosaic mutations in PI3K-AKT-mTOR pathway that encompass a heterogeneous group of rare disorder that are associated with the appearance of overgrowth. CLOVES syndrome and Klippel\u2013Tr\u00e9naunay syndrome are PROS disease. Proteus syndrome is an overgrowth syndrome caused by a somatic activating mutation in AKT1. CLOVES, Klippel\u2013Tr\u00e9naunay and Proteus syndromes are associated with high risk of thrombosis and pulmonary embolism. Hereditary hemorrhagic telangiectasia is an autosomic dominant disorder characterized by the presence of arteriovenous malformations. New therapeutic strategies with bevacizumab and thalidomide have been employed with promising results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000000812","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T09:46:02Z","timestamp":1564393562000},"page":"747-753","source":"Crossref","is-referenced-by-count":74,"title":["Vascular malformations syndromes: an update"],"prefix":"10.1097","volume":"31","author":[{"given":"Antonio","family":"Martinez-Lopez","sequence":"first","affiliation":[{"name":"Dermatology Unit, Hospital Universitario Virgen de las Nieves"},{"name":"Instituto de Investigacio\u0301n Biosanitaria ibs.GRANADA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Salvador-Rodriguez","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Hospital Universitario Virgen de las Nieves"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinidad","family":"Montero-Vilchez","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Hospital Universitario Virgen de las Nieves"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Molina-Leyva","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Hospital Universitario Virgen de las Nieves"},{"name":"Instituto de Investigacio\u0301n Biosanitaria ibs.GRANADA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Tercedor-Sanchez","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Hospital Universitario Virgen de las Nieves"},{"name":"Instituto de Investigacio\u0301n Biosanitaria ibs.GRANADA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Arias-Santiago","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Hospital Universitario Virgen de las Nieves"},{"name":"Instituto de Investigacio\u0301n Biosanitaria ibs.GRANADA"},{"name":"Dermatology Department, University of Granada, Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"127","DOI":"10.23736\/S0392-9590.18.03961-5","article-title":"Vascular malformations: classification, diagnosis and treatment","volume":"37","author":"Carqueja","year":"2018","journal-title":"Int Angiol"},{"key":"R2-20230918","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00006534-198203000-00002","article-title":"Hemangiomas and vascular malformations in infants and children. A classification based on endothelial characteristics","volume":"69","author":"Mulliken","year":"1982","journal-title":"Plast Reconstr Surg"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ajmg.c.31362","article-title":"Molecular mechanisms of childhood overgrowth","volume":"163","author":"Tatton-Brown","year":"2013","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/cge.13543","article-title":"Early activating somatic PIK3CA mutations promote ectopic muscle development and upper limb overgrowth","volume":"96","author":"Frisk","year":"2019","journal-title":"Clin Genet"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.molmed.2018.08.003","article-title":"Cancer-associated PIK3CA mutations in overgrowth disorders","volume":"24","author":"Madsen","year":"2018","journal-title":"Trends Mol Med"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1084\/jem.20181353","article-title":"Somatic activating mutations in PIK3CA cause generalized lymphatic anomaly","volume":"216","author":"Rodriguez-Laguna","year":"2019","journal-title":"J Exp Med"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jmoldx.2017.04.006","article-title":"Molecular diagnosis of mosaic overgrowth syndromes using a custom-designed next-generation sequencing panel","volume":"19","author":"Chang","year":"2017","journal-title":"J Mol Diagn"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41436-018-0297-9","article-title":"Safety and efficacy of low-dose sirolimus in the PIK3CA-related overgrowth spectrum","volume":"21","author":"Parker","year":"2019","journal-title":"Genet Med"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","article-title":"Targeted therapy in patients with PIK3CA-related overgrowth syndrome","volume":"558","author":"Venot","year":"2018","journal-title":"Nature"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"e26684","DOI":"10.1002\/pbc.26684","article-title":"Sonographic screening for Wilms tumor in children with CLOVES syndrome","volume":"64","author":"Peterman","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jvsv.2018.01.015","article-title":"Pulmonary thromboembolic events in patients with congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and spinal\/skeletal abnormalities and Klippel-Tr\u00e9aunay syndrome","volume":"6","author":"Reis","year":"2018","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/cge.13195","article-title":"Causal somatic mutations in urine DNA from persons with the CLOVES subgroup of the PIK3CA-related overgrowth spectrum","volume":"93","author":"Michel","year":"2018","journal-title":"Clin Genet"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jvsv.2016.10.084","article-title":"Diagnosis and management of the venous malformations of Klippel-Tr\u00e9aunay syndrome","volume":"5","author":"Wang","year":"2017","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s11596-018-1964-4","article-title":"Radiological aspect of Klippel-Tr\u00e9aunay syndrome: a case series with review of literature","volume":"38","author":"Alwalid","year":"2018","journal-title":"Curr Med Sci"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1111\/1471-0528.14698","article-title":"Complications of pregnancy and labour in women with Klippel-Tr\u00e9aunay syndrome: a nationwide cross-sectional study","volume":"124","author":"Horbach","year":"2017","journal-title":"BJOG"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jaad.2018.05.1245","article-title":"Pain, psychiatric comorbidities, and psychosocial stressors associated with Klippel-Trenaunay syndrome","volume":"79","author":"Harvey","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1097\/IAE.0000000000001856","article-title":"Choroidal melanoma in phakomatosis pigmentovascularis with Klippel-Trenaunay syndrome","volume":"38","author":"Shields","year":"2018","journal-title":"Retina"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/cge.13145","article-title":"Hypoglycaemia represents a clinically significant manifestation of PIK3CA- and CCND2-associated segmental overgrowth","volume":"93","author":"McDermott","year":"2018","journal-title":"Clin Genet"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/pde.13304","article-title":"Screening for Sturge-Weber syndrome: a state-of-the-art review","volume":"35","author":"Zallmann","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.nrl.2015.12.012","article-title":"Analysis of Sturge-Weber syndrome: a retrospective study of multiple associated variables","volume":"32","author":"Mara\u00f1","year":"2017","journal-title":"Neurologia"},{"key":"R22-20230918","first-page":"409","article-title":"Pathophysiology, diagnosis, and management of glaucoma associated with Sturge-Weber syndrome","volume":"38","author":"Javaid","year":"2018","journal-title":"Int Ophthalmol"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaad.2017.10.018","article-title":"Pathogenetic insights from quantification of the cerebriform connective tissue nevus in Proteus syndrome","volume":"78","author":"Nathan","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1002\/ajmg.a.38311","article-title":"Characterization of thrombosis in patients with Proteus syndrome","volume":"173","author":"Keppler-Noreuil","year":"2017","journal-title":"Am J Med Genet A"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/gim.2017.65","article-title":"Quantifying survival in patients with Proteus syndrome","volume":"19","author":"Sapp","year":"2017","journal-title":"Genet Med"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0268355516664212","article-title":"Parkes Weber syndrome-Diagnostic and management paradigms: A systematic review","volume":"32","author":"Banzic","year":"2017","journal-title":"Phlebology"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-015-3665-z","article-title":"Breast cancer risk and clinical implications for germline PTEN mutation carriers","volume":"165","author":"Ngeow","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1007\/s10620-016-4443-4","article-title":"Say What? Bannayan-Riley-Ruvalcaba syndrome presenting with gastrointestinal bleeding due to hamartoma-induced intussusception","volume":"62","author":"Kethman","year":"2017","journal-title":"Dig Dis Sci"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"325","DOI":"10.21037\/cdt.2018.06.01","article-title":"Pulmonary arteriovenous malformations: diagnosis","volume":"8","author":"Saboo","year":"2018","journal-title":"Cardiovasc Diagn Ther"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"236","DOI":"10.5582\/irdr.2018.01103","article-title":"Uptake and radiological findings of screening cerebral magnetic resonance scans in patients with hereditary haemorrhagic telangiectasia","volume":"7","author":"Fatania","year":"2018","journal-title":"Intractable Rare Dis Res"},{"key":"R31-20230918","article-title":"Endoglin is a conserved regulator of vasculogenesis in zebrafish - implications for hereditary haemorrhagic telangiectasia","volume":"39","author":"Zhang","year":"2019","journal-title":"Biosci Rep"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4193\/Rhin17.166","article-title":"Intranasal bevacizumab in the treatment of HHT -related epistaxis: a systematic review","volume":"56","author":"Stokes","year":"2018","journal-title":"Rhinology"},{"key":"R33-20230918","doi-asserted-by":"crossref","DOI":"10.4193\/Rhin18.289","article-title":"Does severe bleeding in HHT patients respond to intravenous bevacizumab? Review of the literature and case series","author":"Rosenberg","year":"2019","journal-title":"Rhinology"},{"key":"R34-20230918","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1017\/S0022215118001536","article-title":"The use of thalidomide therapy for refractory epistaxis in hereditary haemorrhagic telangiectasia: systematic review","volume":"132","author":"Harrison","year":"2018","journal-title":"J Laryngol Otol"},{"key":"R35-20230918","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13023-018-0982-4","article-title":"Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia","volume":"14","author":"Buscarini","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"R36-20230918","doi-asserted-by":"crossref","first-page":"e026882","DOI":"10.1136\/bmjopen-2018-026882","article-title":"Novel use of tranexamic acid to reduce the need for Nasal Packing in Epistaxis (NoPac) randomised controlled trial: research protocol","volume":"9","author":"Reuben","year":"2019","journal-title":"BMJ Open"},{"key":"R37-20230918","doi-asserted-by":"crossref","DOI":"10.1007\/s00270-019-02204-x","article-title":"Long-term single-center retrospective follow-up after embolization of pulmonary arteriovenous malformations treated over a 20-year period: frequency of re-canalization with various embolization materials and clinical outcome","author":"Andersen","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R38-20230918","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/MPG.0000000000002292","article-title":"Magnetically controlled capsule endoscopy in children: a single center, retrospective cohort study","volume":"69","author":"Gu","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R39-20230918","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.17765","article-title":"Photoacoustic imaging as an innovative technique for the exploration of blue rubber bleb naevus","author":"Lavaud","year":"2019","journal-title":"Br J Dermatol"},{"key":"R40-20230918","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/jgh.14590","article-title":"Gastrointestinal: Endoscopic injection sclerotherapy for duodenal vascular malformation in blue rubber bleb nevus syndrome","volume":"34","author":"Kumei","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"R41-20230918","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s40272-019-00337-7","article-title":"Off-label use of sirolimus and everolimus in a pediatric center: a case series and review of the literature","volume":"21","author":"Bevacqua","year":"2019","journal-title":"Paediatr Drugs"},{"key":"R42-20230918","article-title":"Efficacy and safety of sirolimus in the treatment of blue rubber bleb nevus syndrome in pediatric patients","author":"Zhang","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"R43-20230918","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jaad.2017.11.044","article-title":"A cross-sectional survey of long-term outcomes for patients with diffuse capillary malformation with overgrowth","volume":"78","author":"Liu","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R44-20230918","doi-asserted-by":"crossref","first-page":"e12851","DOI":"10.1111\/dth.12851","article-title":"Unsatisfactory response to sirolimus in Maffucci syndrome-associated spindle cell hemangiomas","volume":"32","author":"Gupta","year":"2019","journal-title":"Dermatol Ther"},{"key":"R45-20230918","doi-asserted-by":"crossref","first-page":"e12919","DOI":"10.1111\/dth.12919","article-title":"Successful treatment of spindle cell hemangiomas in a patient with Maffucci syndrome and review of literatures","volume":"32","author":"Lekwuttikarn","year":"2019","journal-title":"Dermatol Ther"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000812","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T22:24:27Z","timestamp":1694989467000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000812"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000812","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}